Skip to main content
. 2016 Apr 8;57(4):1687–1698. doi: 10.1167/iovs.15-17269

Figure 7.

Figure 7

Higher magnifications of regions of H&E-stained corneas (first and third images in each panel) and corresponding ADAM17 immunofluorescence patterns (second and fourth images in each panel) for unexposed and NM-exposed corneas, plus and minus hydroxamate treatments. (A) Sections of unexposed cornea are on the left; NM-exposed corneas are on the right (no hydroxamate therapy was applied to these). (B) Left: Unexposed corneas treated with NDH4385. Right: NM-exposed corneas that received NDH4385 treatment. (C) Left: Unexposed corneas treated with NDH4409. Right: NM-exposed corneas that received NDH4409 treatment. (D) Left: Unexposed corneas treated with NDH4417. Right: NM-exposed corneas treated with NDH4417. (E) Left: Unexposed corneas that received NDH4450 treatment. Right: NM-exposed corneas that received NDH4450 treatment.